When a biopsy is taken of a suspicious pigmented skin lesion, histological examination is expected to establish the definitive diagnosis. This study evaluated the inter-observer variation of 20 pathologists in the histological diagnosis of a randomly selected set of suspicious pigmented skin lesions (PSLs), by comparing their diagnoses to a reference diagnosis. Overall sensitivity for melanoma was 87%, ranging from 55% to 100% between the observers. Sensitivity was significantly lower for thin (Breslow thickness <1 mm) than for thick melanomas (83% versus 97%, p=0.005). Overall melanoma specificity was 94%, ranging from 83% to 100% between observers. Dysplastic naevus was the most important source of false-positive diagnoses, mainly in situ melanomas. Positive and negative predictive values in the given test set were 75% and 97%, respectively. In the case of melanoma, there was quite some variation in measured Breslow thickness. This would have led to a different therapeutic approach in 12% of the readings. Some of the variation seemed to be due to a different interpretation of the presence of a co-existent naevus. In 9% (3/35) of the readings, participants did not agree on the presence of ulceration. These results reflect a tendency to overdiagnose mainly thin melanomas in general histopathological practice. They also demonstrate variation in the assessment of major prognostic factors of melanoma.
Introduction
Increased awareness of melanoma among health professionals and the public has led to an increase in the number of biopsies of pigmented skin lesions (PSLs) over time [1, 2] . Histological examination is used to predict the biological behaviour of the PSL and to attempt to reach an exact diagnosis. In the case of melanoma, the pathologist evaluates some tumour characteristics which can affect prognosis and patient management, such as the Breslow thickness and the presence or absence of ulceration [3] .
Several studies have shown that pathologists do not always agree on the diagnosis and biological behaviour of PSLs [4] [5] [6] [7] [8] [9] [10] [11] . The assessment of Breslow thickness and ulceration in melanoma, two major prognostic factors in local disease, has been shown to have good reproducibility [8, [12] [13] [14] [15] [16] [17] , but inter-observer agreement for other tumour characteristics such as Clark's level, histological subtype, and the presence or absence of an associated naevus tends to be poor or intermediate at best [8, [12] [13] [14] [15] [16] . Most of these studies were performed among expert pathologists who were presented a highly selected set of slides. Moreover, artificial conditions which can induce inter-observer discordance, such as serial sections or lack of any clinical information, were not always taken into account [18] .
In the present study, a randomly selected set of biopsies of clinically suspicious PSLs was circulated to a group of general pathologists within a routine practice setting. All participants were sent the original slides and provided with the original clinical information. For each slide, information on slide quality and additional investigations that would be performed in routine practice was acquired.
recruited during a medical education session on breast pathology.
Slides were sent to the participants in sets of 6-7. The pathologist was asked to complete a standard protocol (Table 1) for each slide and to return it with the slides within 2 weeks. The protocol was approved by all participants before the start of the study. Each protocol was marked with a code specific for the pathologist. The top of the protocol mentioned the slide number and the clinical information provided on the original pathology request form. Pathologists were asked whether each slide was sufficient to establish a definitive diagnosis. They were then asked to make a diagnosis, selecting one of the proposed diagnostic classes. No discussion on the diagnostic criteria was organized prior to the study, as the purpose was to check variability in a normal routine practice setting. In cases of in situ or invasive melanoma, participants were asked to evaluate some additional characteristics. Criteria for classifying histological subtype and Clark's level, and for measuring Breslow thickness, were summarized on the protocol.
One set of six slides was sent twice to each participant to evaluate intra-observer variability. Not all pathologists completed all sets of slides (90% of all expected evaluations); the most frequent reason given was lack of time. Sensitivity, specificity, and predictive value of a diagnosis were calculated by comparison with a reference diagnosis [19] : this was the initial diagnosis made at the dermatopathology department, if more than 80% of all pathologists agreed, or the diagnosis made by a panel of expert (dermato)pathologists (EG, EH, JMN or DR, GP, JMN). In addition, the panel reviewed all slides where an original diagnosis of melanoma was made. A total of 50 slides were reviewed by the panel. In two slides, the panel did not agree on whether the lesion was malignant or benign and these slides were omitted from the analysis. In another two slides, there was disagreement on the exact diagnostic class of the lesion (common versus atypical naevus and congenital versus common naevus). The other slides consisted of 11 melanomas (nine invasive, one in situ, one metastasis), 46 naevi (32 common, seven atypical, three blue, two congenital, two Reed's), and five non-melanocytic lesions.
The chi-squared test was used to test for difference of proportions [20] . The Spearman rank correlation coefficient was used to test a linear correlation between two continuous variables [21] . The sign test was used to test for a trend in a series of categorical values [22] .
Results
The mean number of practising years among participating pathologists was 14 years (range 0.5-34 years). The load of PSLs in routine practice ranged from 4 to 50 per week, with a mean of 16.
Overall, 91% of all slides were found convenient for adequate evaluation by the participants (range 77-97%). Reported slide reading suitability was lower in melanoma than non-melanoma lesions [86% versus 92% ( p=0.015)]. Reasons for poor slide reading suitability were remarks about slide preparation (45%), such as staining and thickness of the sections, and insufficient material to establish a definitive diagnosis (39%). Some other reasons were insufficient clinical information (7%), the need for additional investigations such as immunohistochemistry (5%), and damage to the slide (4%). The panel considered 44 of the 48 slides (92%) adequate for evaluation.
In 46% of the melanoma lesions (range from 0 to 100% among observers) and 12% of the non-melanoma lesions (range from 0 to 58% among observers), the participants would have performed immunohistochemistry in routine practice. Sixty-five per cent of the additional immunohistochemical examinations would have consisted of HMB45 and/or S100. Common leukocyte antigen (CLA), trichrome or vimentin detection would have been performed in another 7% of the slide readings. The panel would have performed additional immunohistochemistry in five of the 48 slides (10%), with S100 and/or HMB45 in 80%.
In 49% of the melanoma lesions [range from 9% (1/11) to 100% (11/11)] and in 24% of the nonmelanoma lesions [range from 7% (4/54) to 73% (37/ 51)], participants would have discussed the slide with a colleague or would have consulted a book in routine practice. In 15% of the melanoma evaluations and in 9% of the non-melanoma lesions, they effectively did so. The frequency with which they would seek advice was negatively correlated with their experience (number of practice years multiplied by the load of PSLs seen in everyday practice) in non-melanoma lesions (r=x0.61, p<0.01). This correlation was not statistically significant in melanoma lesions (r=x0.40, p=0.12).
Melanoma sensitivity and specificity
Overall sensitivity for melanoma was 87% (range 55-100%) ( Table 2 ). Sensitivity was higher in thick melanomas (Breslow thickness >1 mm) than in thin melanomas [97% versus 83% ( p=0.005)]. Other suggested diagnoses were dysplastic naevus (12%, with 11% compound type) and common compound naevus (5%) in case of thin melanomas, and Spitz (2%) and dysplastic compound naevus (1%) in case of thick melanomas.
Overall melanoma specificity was 94% (range 83-100%) ( Table 2 ). False-positive melanoma diagnoses were made in dysplastic naevi (46%, with 44% of junction type), blue naevi (30%), common naevi (14%, with 11% of junctional type), Reed's naevus (4%), and in a non-melanocytic lesion (7%) ( Table 3) . Most false-positive melanoma diagnoses were in situ (Table 3) , especially in one particular slide.
Leaving out those slides that were considered not optimal for evaluation did not change sensitivity and specificity significantly ( p>0.05). Excluding those readings where a second opinion and/or additional immunohistochemistry would have been asked in normal routine practice did not affect melanoma sensitivity ( p>0.05), while it increased melanoma specificity from 94% to 98% ( p=0.0001).
There was no correlation of melanoma sensitivity and specificity with years of practice or the routine load of PSLs ( p>0.05). There was a negative correlation between the ability to recognize benign disease (melanoma specificity) and the frequency with which a colleague or a textbook would have been consulted in routine practice (r=x0.52, p<0.001).
In the set of six slides that was sent twice, six different pathologists switched from melanoma to a benign PSL, or vice versa, in five different slides. The second reading tended to be more in agreement with the reference diagnosis (96% versus 87%; x 2 =4.39, p=0.04).
Evaluation of melanoma characteristics
Of the ten primary melanomas (one in situ, nine invasive), five were classified by the panel as the superficial spreading type. One was considered lentigo maligna melanoma and three were judged not classifiable. Participants' agreement with the panel was 55%. Agreement on the four superficial spreading melanomas reached 93%, while agreement for the other tumours was only 21%.
The panel of experts reported ulceration in two thick melanomas (Breslow depth of 2.6 and 3.3 mm). Participants did not agree in three of the 35 readings (9%). Overall agreement on the presence or absence of ulceration was 98%.
There was 77% agreement on the evaluation of the presence or absence of an associated naevus. The lowest agreement (24%) was found in the two slides where the panel concluded that an associated naevus was present. Agreement on Clark's level was highest in level II (81%) and lowest in level III (26%). Agreement for Clark's level IV was 65%. The observers' and panel's observation of the level of invasion was concordant in 59% of all evaluations. In 30% of the evaluations, the level reported by the participants was one level lower (20%) or higher (10%) than that of the panel. In 11% of the evaluations, there were two levels of difference with the panel (all lower). Pathologists tended to underscore Clark's level compared with the panel ( p<0.001).
The mean difference of Breslow thickness assessed by the pathologist and by the panel was x0.09 mm (SD=0.52), but the extremes ranged from x2.40 mm to +1.67 mm. The range of differences varied considerably with the observer and with the slide (Figure 1a and 1b) . Variation tended to be higher in thicker tumours (Figure 1b ). Discordant evaluations of an associated naevus seemed to be at the basis of some of the observed differences in measured Breslow thickness (Figures 1a and 1b) . For 12% of all evaluations there would have been different patient management, based on the Breslow thickness assessed by the pathologist or by the panel (cut-off at 1 mm depth).
Diagnostic classification of benign lesions
On 53 PSLs that were considered benign, the panel did not agree on the exact diagnostic class of two. These two slides were omitted from this analysis.
Overall, there was 70% agreement on the diagnostic classification of benign melanocytic lesions. The majority of these lesions were common naevi and the pathologists had a concordant diagnosis (including naevoid lentigo) in 78% of all evaluations (Table 3 ). In nearly 11%, a diagnosis of dysplastic naevus was made.
In situ melanoma was diagnosed in five different slides by five different pathologists, and invasive melanoma was diagnosed in two readings (one Breslow missing and the other 0.90 mm).
In 45.6% of their evaluations, pathologists agreed with the reference diagnosis of dysplastic naevus ( Table 3 ). Four of the seven slides with a reference diagnosis of dysplastic naevus gave rise to 22 falsepositive diagnoses of in situ melanoma. In addition, four false-positive diagnoses of invasive melanoma (Breslow ranging from 0.26 to 0.75 mm) were made (three different slides, three different pathologists).
All three slides of blue naevi caused problems of diagnostic classification (Table 3) . A diagnosis of melanoma metastasis was suggested in 16 evaluations. In 13, this was due to one particular slide where the PSL had been excised near the scar of a former melanoma resection. In the latter slide, there was also one false-positive diagnosis of invasive melanoma, Breslow 2.8 mm.
Reed's naevus was recognized in 47.4% of all evaluations. In about one-third, it was diagnosed as dysplastic naevus. There was one diagnosis of melanoma in situ and one of invasive melanoma (Breslow 0.77 mm).
Three non-melanocytic lesions were diagnosed as melanocytic by five different pathologists: a dermatofibroma was diagnosed as a desmoplastic naevus and an angioma as a common naevus; an early evolving seborrhoeic keratosis was diagnosed four times as melanoma in situ, of which two were classified as Dubreuilh's melanosis. One seborrhoeic keratosis was diagnosed twice as basal cell carcinoma.
In the set of benign melanocytic lesions that was read twice by the participants (three common naevi, one dysplastic naevus, and one Reed's naevus), the diagnostic class was changed in 23% of the second 
Discussion
In this study, a randomly selected set of biopsies of PSLs with one or more clinically suspicious features was circulated to a group of volunteer general pathologists with a routine practice. Care was taken to avoid conditions which could induce inter-observer variability [18, 23] . Overall sensitivity for melanoma was 87%. Sensitivity was significantly lower in thin melanomas (Breslow<1 mm), where one in six readings resulted in a diagnosis of naevus (mainly dysplastic and mainly of the compound type). Inter-observer variation in thin melanomas, which have shown a considerable increase in the second half of the 20th century [24] , has been reported [7, 8] and the exact malignant potential of these lesions has been discussed [25] . The concept of radial growth phase (RGP) melanoma, which was proposed by Clark et al. in 1984 [26] , implies a progression stage of invasive melanoma incapable of metastasis [27] . Inter-observer variation for the recognition of RGP versus vertical growth phase (VGP) in melanoma ranged from fair to good [10, 17] .
In the present study, melanoma specificity was 94%, increasing to 98% excluding the readings where additional advice or immunohistochemistry was not performed while it would have been in normal routine practice. The negative correlation between specificity and the frequency with which a colleague or textbook would have been consulted in routine practice could indicate a tendency to overdiagnose melanoma in case of doubt about the biological behaviour of the lesion. A tendency to overdiagnose thin melanomas has been reported [7] . Dysplastic naevi of the junctional type were the PSLs most often misdiagnosed as melanoma, mainly melanoma in situ. Cook et al. suggested the use of the MIN (melanocytic intraepidermal neoplasia) terminology, by analogy with CIN (cervical intraepithelial neoplasia), because of the difficulty in discriminating between (severely) dysplastic naevi and in situ/RGP melanoma [7, 10] . However, dysplastic naevi and in situ/ RGP melanoma may have a different clinical significance. While the latter are considered progression stages of malignant disease [26] , the clinical significance of naevi with histological dysplasia is not established and its prevalence in the normal population has been estimated from 10% up to 47% [28, 29] . In contrast, clinically atypical naevi are a marker for increased melanoma susceptibility and are possible precursor lesions of melanoma [30] [31] [32] [33] . There is a poor correlation between clinical atypia and the presence of histological dysplasia [33] . Studies on the recognition of naevi with histological dysplasia have shown divergent results [34] . In this study, less than 50% of the dysplastic naevi were classified as such. However, histopathological criteria for diagnosing dysplastic naevi have been shown to be reproducible [35, 36] and problems seem to lie mainly at the extremes of the spectrum (dysplastic naevi with severe dysplasia versus melanoma in situ, dysplastic naevi with mild dysplasia versus common naevus) [5, 35] .
Despite the relatively high specificity for melanoma, there is an important number of false-positive melanoma diagnoses, because the majority of the PSLs presented to the pathologist are benign: in 6% of the readings of 53 benign PSLs, the pathologist did not agree with the innocuous nature of the lesion, resulting in 57 false melanoma diagnoses, consisting mainly of in situ melanomas and thin invasive melanomas. This important 'burden' of false-positive diagnoses is also reflected by the positive predictive value in the current study setting (Table 2) : overall, one-quarter of all melanoma diagnoses were made in benign lesions. On the other hand, the negative predictive value in the current test setting was high (97%), indicating that the risk for a patient having melanoma in the event of a negative diagnosis is low. It is likely that in general histology practice the ratio of benign/malignant lesions is even higher than in this experimental setting (4.8 : 1), which would further reduce the calculated positive predictive value of a melanoma diagnosis.
In the set of six slides that was sent twice, the second reading tended to be more in agreement with the reference diagnosis, indicating a learning effect and/or habituation to the specific slide processing characteristics.
Even among experts, there may be disagreement on the estimated biological behaviour of PSL [9, 11] and the only certainty about the benign/malignant nature of a lesion is the eventual outcome for the patient.
Thickness measured according to Breslow is a major prognostic factor in local disease, on which further management is often based [3] . Despite the fact that this is an objective, reproducible measurement [8, [12] [13] [14] 16, 17] , this study indicates that there is still an important variation in routine practice, with possible therapeutic implications for the patient. Errors inherent in the measuring instrument may be expected to produce variations of 0.1-0.5 mm [12, 14] . Other variations may be due to different interpretations of the deepest invasive tumour cell [12, 14] . In this study, some of the differences in measured Breslow thickness between the participants and the panel seemed to be related to a different interpretation of the presence or absence of a co-existent naevus. Larger variations may be attributable to errors in the conversion of micrometre units into millimetres [12, 14] . Finally, although we presumed that participating pathologists used the same measuring technique and criteria (described on the protocol), some may use other techniques in routine practice [37] . Clark's level has been reported to be less reproducible than Breslow thickness [8, [12] [13] [14] 17] . This is probably inherent in the fact that it is a categorical variable, forcing the pathologist to choose one category [12, 13] . The lowest agreement has been observed for Clark level III. This has been attributed to the difficulty in assessing the interface between papillary and reticular dermis [12, 13] .
Ulceration is the second major independent prognostic factor in local disease, which will be incorporated in the new pTNM staging system [3] . In this study, the presence of ulceration was missed in two melanoma cases by three pathologists. Although several studies reported good reproducibility of this characteristic [8, 13, 16] , Heenan et al. reported that inter-observer congruence was lower than one might expect. They suggested that this might be related to the recognition of small foci of ulceration (less than 3 mm wide), of which the prognostic significance is questionable [13] . However, the areas of ulceration in this study were clearly wider, so that discordant observations probably pertain to inaccuracy of the observer.
In conclusion, the increased presentation of borderline lesions seems to have complicated the histopathological diagnosis of PSLs. On the one hand, a proportion of the melanomas removed in an early phase of tumour progression may not be recognized; many of these lesions, however, may not display clinically aggressive behaviour [27, 38] . On the other hand, there may also be an ongoing overdiagnosis of (especially thin) melanomas, which may be further stimulated by increased awareness and the pressure not to miss such an important diagnosis as melanoma.
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cost, both at the community and at the individual level, of melanoma under-and over-diagnosis in general histopathological practice. In this study, 13% of the readings were reclassified from benign to malignant and 2-6% were reclassified in the other direction. Since melanoma is a relatively infrequent cancer in most European countries, it is likely that patients receiving an inappropriate diagnosis of melanoma outnumber those in whom melanoma is missed. It also implies that the histological diagnosis of a benign lesion is probably more reliable than that of a malignant lesion (with a high negative predictive value and a lower positive predictive value). These phenomena are inherent in the fact that histological diagnosis is based on the interpretation of a visual image, which is subjective to some extent [9, 39] . New diagnostic techniques for detecting genetic or functional changes specific for the malignant transformation of melanocytes would bring significant progress in the classification of borderline lesions.
